EVIDENCE FOR INVIVO BINDING OF APOMORPHINE AND BROMOCRIPTINE TO RECEPTOR-SITES NOT LABELED BY SPIPERONE-H-3

被引:21
作者
KOHLER, C [1 ]
FUXE, K [1 ]
OGREN, SO [1 ]
AGNATI, L [1 ]
机构
[1] KAROLINSKA INST,DEPT HISTOL,S-10401 STOCKHOLM 60,SWEDEN
关键词
D O I
10.1016/0014-2999(79)90485-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:339 / 340
页数:2
相关论文
共 5 条
[1]  
FUXE K, 1979, DOPAMINERGIC ERGOT D
[2]   REGIONAL DISPLACEMENT BY SULPIRIDE OF [SPIPERONE-H-3 BINDING INVIVO - BIOCHEMICAL AND BEHAVIORAL EVIDENCE FOR A PREFERENTIAL ACTION ON LIMBIC AND NIGRAL DOPAMINE RECEPTORS [J].
KOHLER, C ;
OGREN, SO ;
HAGLUND, L ;
ANGEBY, T .
NEUROSCIENCE LETTERS, 1979, 13 (01) :51-56
[3]   DOPAMINE RECEPTOR-BINDING INVIVO - FEASIBILITY OF AUTORADIOGRAPHIC STUDIES [J].
KUHAR, MJ ;
MURRIN, LC ;
MALOUF, AT ;
KLEMM, N .
LIFE SCIENCES, 1978, 22 (02) :203-210
[4]   SPIPERONE - LIGAND OF CHOICE FOR NEUROLEPTIC RECEPTORS .2. REGIONAL DISTRIBUTION AND INVIVO DISPLACEMENT OF NEUROLEPTIC DRUGS [J].
LADURON, PM ;
JANSSEN, PFM ;
LEYSEN, JE .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (03) :317-321
[5]   DIFFERENTIAL CENTRIFUGATION OF APOMORPHINE-H-3 AND H-3-SPIROPERIDOL BINDING-SITES [J].
TITELER, M ;
SEEMAN, P ;
HENN, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 51 (04) :459-460